# Scientific Summary

**Prompt:** Recent developments in generative AI for protein structure prediction and drug discovery

**Summary:**
Recent advancements in generative AI have significantly impacted protein structure prediction and drug discovery, as highlighted by several key studies. 

1. **SuperMetal: A Generative AI Framework for Rapid and Precise Metal Ion Location Prediction in Proteins** - This paper introduces SuperMetal, a generative AI framework that utilizes a score-based diffusion model to accurately predict metal-binding sites in proteins. This advancement is crucial for understanding enzymatic activities and protein interactions, which are vital for protein engineering and drug discovery.

2. **Artificial Intelligence: A New Tool for Structure-Based G Protein-Coupled Receptor Drug Discovery** - This study discusses the role of AI in overcoming the limitations of traditional experimental methods for determining protein structures. By leveraging AI, researchers can enhance the scalability and efficiency of structure-based drug discovery, particularly for G protein-coupled receptors, which are significant drug targets.

3. **Ligand-Based Drug Discovery Leveraging State-of-the-Art Machine Learning Methodologies Exemplified by Cdr1 Inhibitor Prediction** - This research emphasizes the use of AI in ligand-based drug discovery, especially when experimental structures or high-confidence models are unavailable. The development of predictive AI models enhances the efficiency and accuracy of identifying potential drug candidates.

4. **Emerging Horizons of AI in Pharmaceutical Research** - This paper provides a comprehensive overview of how AI revolutionizes drug discovery by integrating vast biological and chemical data. AI techniques, including machine learning and QSAR models, are applied to predict compound behaviors and potential drug candidates, streamlining the drug discovery process.

5. **Identifying Novel Drug Targets with Computational Precision** - This study highlights the integration of algorithms and high-performance computing in drug discovery, which allows for the precise analysis of complex biological data. This approach accelerates the identification of therapeutic targets, enhancing the speed and precision of drug discovery.

These studies collectively demonstrate the transformative impact of generative AI in protein structure prediction and drug discovery, offering new methodologies and tools that enhance the efficiency, accuracy, and scalability of these processes.

---

## Information on the total number of items extracted, including those identified as most relevant by the agent (10)

### 1. Discovery of Z1362873773: a novel fascin inhibitor from a large chemical library for colorectal cancer.
- **Date:** 2025-04-28
- **Source:** PubMed
- **URL:** [https://pubmed.ncbi.nlm.nih.gov/40295602](https://pubmed.ncbi.nlm.nih.gov/40295602)
- **DOI:** 10.1038/s41598-025-96457-x
- **Abstract:** Metastasis is one of the leading causes of cancer-related death worldwide. Fascin, a protein that bundles actin filaments to produce protrusions in cancer cells, plays a significant role in the enhancement of cell migration. This protein has been shown that the overexpression of this protein is related to the appearance of different types of cancer, such as colorectal cancer. In this study, we conducted in silico screening of the Enamine library, a compound library with a broad chemical space. U...

### 2. Ligand-Based Drug Discovery Leveraging State-of-the-Art Machine Learning Methodologies Exemplified by Cdr1 Inhibitor Prediction.
- **Date:** 2025-04-16
- **Source:** PubMed
- **URL:** [https://pubmed.ncbi.nlm.nih.gov/40241349](https://pubmed.ncbi.nlm.nih.gov/40241349)
- **DOI:** 10.1021/acs.jcim.5c00374
- **Abstract:** Artificial intelligence (AI) is revolutionizing drug discovery with unprecedented speed and efficiency. In computer-aided drug design, structure-based and ligand-based methodologies are the main driving forces for innovation. In cases where no experimental structure or high-confidence homology/AlphaFold-predicted model of the target is available in 3D, ligand-based strategies are generally preferable. Here, we aim to develop and evaluate new predictive AI models for ligand-based drug discovery. ...

### 3. Ternary Complex Modeling, Induced Fit Docking and Molecular Dynamics Simulations as a Successful Approach for the Design of VHL-Mediated PROTACs Targeting the Kinase FLT3.
- **Date:** 2025-04-01
- **Source:** PubMed
- **URL:** [https://pubmed.ncbi.nlm.nih.gov/40223615](https://pubmed.ncbi.nlm.nih.gov/40223615)
- **DOI:** 10.1002/ardp.202500102
- **Abstract:** Proteolysis targeting chimeras (PROTACs) have proven to be a novel approach for the degradation of disease-causing proteins in drug discovery. One of the E3 ligases for which efficient PROTACs have been described is the Von Hippel-Lindau factor (VHL). However, the development of PROTACs has so far often relied on a minimum of computational tools, so that it is mostly based on a trial-and-error process. Therefore, there is a great need for resource- and time-efficient structure-based or computati...

### 4. SuperMetal: A Generative AI Framework for Rapid and Precise Metal Ion Location Prediction in Proteins.
- **Date:** 2025-03-25
- **Source:** PubMed
- **URL:** [https://pubmed.ncbi.nlm.nih.gov/40196543](https://pubmed.ncbi.nlm.nih.gov/40196543)
- **DOI:** 10.1101/2025.03.21.644685
- **Abstract:** Metal ions, as abundant and vital cofactors in numerous proteins, are crucial for enzymatic activities and protein interactions. Given their pivotal role and catalytic efficiency, accurately and efficiently identifying metal-binding sites is fundamental to elucidating their biological functions and has significant implications for protein engineering and drug discovery. To address this challenge, we present SuperMetal, a generative AI framework that leverages a score-based diffusion model couple...

### 5. Topology-Driven Negative Sampling Enhances Generalizability in Protein-Protein Interaction Prediction.
- **Date:** 2025-04-07
- **Source:** PubMed
- **URL:** [https://pubmed.ncbi.nlm.nih.gov/40193392](https://pubmed.ncbi.nlm.nih.gov/40193392)
- **DOI:** 10.1093/bioinformatics/btaf148
- **Abstract:** Unraveling the human interactome to uncover disease-specific patterns and discover drug targets hinges on accurate protein-protein interaction (PPI) predictions. However, challenges persist in machine learning (ML) models due to a scarcity of quality hard negative samples, shortcut learning, and limited generalizability to novel proteins....

### 6. A workflow to create a high-quality protein-ligand binding dataset for training, validation, and prediction tasks.
- **Date:** 2025-04-02
- **Source:** PubMed
- **URL:** [https://pubmed.ncbi.nlm.nih.gov/40190768](https://pubmed.ncbi.nlm.nih.gov/40190768)
- **DOI:** 10.1039/d4dd00357h
- **Abstract:** Development of scoring functions (SFs) used to predict protein-ligand binding energies requires high-quality 3D structures and binding assay data for training and testing their parameters. In this work, we show that one of the widely-used datasets, PDBbind, suffers from several common structural artifacts of both proteins and ligands, which may compromise the accuracy, reliability, and generalizability of the resulting SFs. Therefore, we have developed a series of algorithms organized in a semi-...

### 7. Emerging horizons of AI in pharmaceutical research.
- **Date:** 2025-02-16
- **Source:** PubMed
- **URL:** [https://pubmed.ncbi.nlm.nih.gov/40175048](https://pubmed.ncbi.nlm.nih.gov/40175048)
- **DOI:** 10.1016/bs.apha.2025.01.016
- **Abstract:** Artificial Intelligence (AI) has revolutionized drug discovery by enhancing data collection, integration, and predictive modeling across various critical stages. It aggregates vast biological and chemical data, including genomic information, protein structures, and chemical interactions with biological targets. Machine learning techniques and QSAR models are applied by AI to predict compound behaviors and predict potential drug candidates. Docking simulations predict drug-protein interactions, w...

### 8. Identifying novel drug targets with computational precision.
- **Date:** 2025-02-06
- **Source:** PubMed
- **URL:** [https://pubmed.ncbi.nlm.nih.gov/40175044](https://pubmed.ncbi.nlm.nih.gov/40175044)
- **DOI:** 10.1016/bs.apha.2025.01.003
- **Abstract:** Computational precision in drug discovery integrates algorithms and high-performance computing to analyze complex biological data with unprecedented accuracy, revolutionizing the identification of therapeutic targets. This process encompasses diverse computational and experimental approaches that enhance drug discovery's speed and precision. Advanced techniques like next-generation sequencing enable rapid genetic characterization, while proteomics explores protein expression and interactions dri...

### 9. Leveraging AI to Explore Structural Contexts of Post-Translational Modifications in Drug Binding.
- **Date:** 2025-03-20
- **Source:** PubMed
- **URL:** [https://pubmed.ncbi.nlm.nih.gov/40166291](https://pubmed.ncbi.nlm.nih.gov/40166291)
- **DOI:** 10.1101/2025.01.14.633078
- **Abstract:** Post-translational modifications (PTMs) play a crucial role in allowing cells to expand the functionality of their proteins and adaptively regulate their signaling pathways. Defects in PTMs have been linked to numerous developmental disorders and human diseases, including cancer, diabetes, heart, neurodegenerative and metabolic diseases. PTMs are important targets in drug discovery, as they can significantly influence various aspects of drug interactions including binding affinity. The structura...

### 10. Artificial Intelligence: A New Tool for Structure-Based G Protein-Coupled Receptor Drug Discovery.
- **Date:** 2025-03-17
- **Source:** PubMed
- **URL:** [https://pubmed.ncbi.nlm.nih.gov/40149959](https://pubmed.ncbi.nlm.nih.gov/40149959)
- **DOI:** 10.3390/biom15030423
- **Abstract:** Understanding protein structures can facilitate the development of therapeutic drugs. Traditionally, protein structures have been determined through experimental approaches such as X-ray crystallography, NMR spectroscopy, and cryo-electron microscopy. While these methods are effective and are considered the gold standard, they are very resource-intensive and time-consuming, ultimately limiting their scalability. However, with recent developments in computational biology and artificial intelligen...
